Atria Investments LLC boosted its position in MetLife, Inc. (NYSE:MET) by 0.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,986 shares of the financial services provider’s stock after buying an additional 72 shares during the period. Atria Investments LLC’s holdings in MetLife were worth $1,043,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in MET. BlackRock Inc. increased its stake in MetLife by 3,323.3% in the first quarter. BlackRock Inc. now owns 68,475,870 shares of the financial services provider’s stock worth $3,616,895,000 after buying an additional 66,475,603 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of MetLife by 3.0% in the first quarter. Vanguard Group Inc. now owns 65,364,620 shares of the financial services provider’s stock valued at $3,452,559,000 after buying an additional 1,885,246 shares during the last quarter. Renaissance Technologies LLC bought a new stake in shares of MetLife during the first quarter valued at $82,954,000. APG Asset Management N.V. increased its stake in shares of MetLife by 53.8% in the first quarter. APG Asset Management N.V. now owns 3,902,274 shares of the financial services provider’s stock valued at $206,118,000 after buying an additional 1,365,018 shares during the last quarter. Finally, Canada Pension Plan Investment Board increased its stake in shares of MetLife by 115.5% in the first quarter. Canada Pension Plan Investment Board now owns 2,367,139 shares of the financial services provider’s stock valued at $125,032,000 after buying an additional 1,268,600 shares during the last quarter. Institutional investors own 74.83% of the company’s stock.

Shares of MetLife, Inc. (NYSE:MET) traded up 0.15% during midday trading on Friday, reaching $46.81. The company had a trading volume of 6,437,764 shares. The firm’s 50 day moving average price is $48.80 and its 200-day moving average price is $47.31. MetLife, Inc. has a 1-year low of $35.64 and a 1-year high of $51.77. The stock has a market capitalization of $49.75 billion, a price-to-earnings ratio of 550.71 and a beta of 1.46.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.28 by $0.02. The business had revenue of $17.39 billion during the quarter, compared to analyst estimates of $17.11 billion. MetLife had a return on equity of 8.51% and a net margin of 0.30%. MetLife’s revenue was up 2.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.83 EPS. Equities research analysts expect that MetLife, Inc. will post $4.91 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Monday, August 7th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 3.42%. The ex-dividend date is Thursday, August 3rd. MetLife’s dividend payout ratio (DPR) is presently 1,777.98%.

ILLEGAL ACTIVITY NOTICE: This piece was posted by Watch List News and is owned by of Watch List News. If you are reading this piece on another site, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this piece can be read at https://www.watchlistnews.com/atria-investments-llc-purchases-72-shares-of-metlife-inc-nysemet/1478414.html.

Several analysts have weighed in on the company. BidaskClub upgraded MetLife from a “sell” rating to a “hold” rating in a research report on Wednesday. Zacks Investment Research downgraded MetLife from a “hold” rating to a “sell” rating in a research report on Wednesday. Wells Fargo & Company reiterated a “buy” rating on shares of MetLife in a research report on Saturday, July 1st. ValuEngine upgraded MetLife from a “buy” rating to a “strong-buy” rating in a research report on Friday. Finally, TheStreet upgraded MetLife from a “c” rating to a “b-” rating in a research report on Monday, July 24th. Two analysts have rated the stock with a sell rating, six have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. MetLife currently has a consensus rating of “Hold” and an average price target of $59.17.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.